annual FCF:
-$391.53M-$76.97M(-24.47%)Summary
- As of today (June 1, 2025), AGIO annual free cash flow is -$391.53 million, with the most recent change of -$76.97 million (-24.47%) on December 31, 2024.
- During the last 3 years, AGIO annual FCF has risen by +$21.54 million (+5.21%).
- AGIO annual FCF is now -1466.73% below its all-time high of $28.65 million, reached on December 31, 2016.
Performance
AGIO Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
-$112.25M+$21.88M(+16.31%)Summary
- As of today (June 1, 2025), AGIO quarterly free cash flow is -$112.25 million, with the most recent change of +$21.88 million (+16.31%) on March 31, 2025.
- Over the past year, AGIO quarterly FCF has dropped by -$12.25 million (-12.25%).
- AGIO quarterly FCF is now -172.38% below its all-time high of $155.09 million, reached on June 30, 2016.
Performance
AGIO quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$403.77M-$12.25M(-3.13%)Summary
- As of today (June 1, 2025), AGIO TTM free cash flow is -$403.77 million, with the most recent change of -$12.25 million (-3.13%) on March 31, 2025.
- Over the past year, AGIO TTM FCF has dropped by -$84.79 million (-26.58%).
- AGIO TTM FCF is now -655.25% below its all-time high of $72.72 million, reached on June 30, 2016.
Performance
AGIO TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
AGIO Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -24.5% | -12.3% | -26.6% |
| 3 y3 years | +5.2% | -11.7% | -3.0% |
| 5 y5 years | -2.3% | -2.5% | -4.4% |
AGIO Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -24.6% | +5.2% | -69.4% | +16.3% | -34.6% | at low |
| 5 y | 5-year | -28.4% | +5.2% | -124.7% | +16.3% | -34.6% | +2.3% |
| alltime | all time | -1466.7% | +5.2% | -172.4% | +16.3% | -655.3% | +2.3% |
AGIO Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$112.25M(-16.3%) | -$403.77M(+3.1%) |
| Dec 2024 | -$391.53M(+24.5%) | -$134.13M(+58.5%) | -$391.53M(+18.6%) |
| Sep 2024 | - | -$84.64M(+16.3%) | -$330.11M(+1.6%) |
| Jun 2024 | - | -$72.75M(-27.3%) | -$324.99M(+1.9%) |
| Mar 2024 | - | -$100.01M(+37.5%) | -$318.99M(+1.4%) |
| Dec 2023 | -$314.56M(+0.1%) | -$72.72M(-8.5%) | -$314.56M(+2.1%) |
| Sep 2023 | - | -$79.51M(+19.1%) | -$308.12M(+2.7%) |
| Jun 2023 | - | -$66.75M(-30.2%) | -$299.99M(-3.0%) |
| Mar 2023 | - | -$95.58M(+44.2%) | -$309.40M(-1.6%) |
| Dec 2022 | -$314.36M(-23.9%) | -$66.28M(-7.2%) | -$314.36M(-6.6%) |
| Sep 2022 | - | -$71.39M(-6.3%) | -$336.68M(-3.9%) |
| Jun 2022 | - | -$76.16M(-24.3%) | -$350.45M(-10.6%) |
| Mar 2022 | - | -$100.54M(+13.5%) | -$391.84M(-5.1%) |
| Dec 2021 | -$413.06M(+35.5%) | -$88.59M(+4.0%) | -$413.06M(+10.3%) |
| Sep 2021 | - | -$85.16M(-27.5%) | -$374.43M(+3.2%) |
| Jun 2021 | - | -$117.54M(-3.5%) | -$362.67M(+14.4%) |
| Mar 2021 | - | -$121.76M(+143.7%) | -$317.07M(+4.0%) |
| Dec 2020 | -$304.87M(-20.3%) | -$49.96M(-31.9%) | -$304.87M(-14.2%) |
| Sep 2020 | - | -$73.41M(+2.0%) | -$355.20M(-3.8%) |
| Jun 2020 | - | -$71.94M(-34.3%) | -$369.41M(-4.5%) |
| Mar 2020 | - | -$109.55M(+9.2%) | -$386.89M(+1.1%) |
| Dec 2019 | -$382.65M(+22.9%) | -$100.29M(+14.5%) | -$382.65M(+7.0%) |
| Sep 2019 | - | -$87.63M(-2.0%) | -$357.60M(+6.1%) |
| Jun 2019 | - | -$89.42M(-15.1%) | -$336.95M(+6.5%) |
| Mar 2019 | - | -$105.31M(+40.0%) | -$316.28M(+1.6%) |
| Dec 2018 | -$311.41M | -$75.24M(+12.3%) | -$311.41M(-0.2%) |
| Sep 2018 | - | -$66.98M(-2.6%) | -$311.90M(-3.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2018 | - | -$68.76M(-31.5%) | -$324.66M(+2.8%) |
| Mar 2018 | - | -$100.43M(+32.6%) | -$315.92M(+9.0%) |
| Dec 2017 | -$289.86M(-1111.8%) | -$75.73M(-5.0%) | -$289.86M(+8.7%) |
| Sep 2017 | - | -$79.73M(+32.8%) | -$266.57M(+11.4%) |
| Jun 2017 | - | -$60.02M(-19.3%) | -$239.29M(+889.7%) |
| Mar 2017 | - | -$74.37M(+41.8%) | -$24.18M(-184.4%) |
| Dec 2016 | $28.65M(-129.5%) | -$52.45M(-0.0%) | $28.65M(-40.8%) |
| Sep 2016 | - | -$52.46M(-133.8%) | $48.38M(-33.5%) |
| Jun 2016 | - | $155.09M(-819.9%) | $72.72M(-181.5%) |
| Mar 2016 | - | -$21.54M(-34.2%) | -$89.27M(-8.1%) |
| Dec 2015 | -$97.11M(+57.7%) | -$32.72M(+16.4%) | -$97.11M(+31.8%) |
| Sep 2015 | - | -$28.11M(+307.3%) | -$73.66M(+5.8%) |
| Jun 2015 | - | -$6.90M(-76.5%) | -$69.64M(+9.0%) |
| Mar 2015 | - | -$29.38M(+217.2%) | -$63.90M(+3.8%) |
| Dec 2014 | -$61.57M(+6.7%) | -$9.26M(-61.6%) | -$61.57M(-6.9%) |
| Sep 2014 | - | -$24.09M(+1982.5%) | -$66.14M(+15.8%) |
| Jun 2014 | - | -$1.16M(-95.7%) | -$57.13M(-21.2%) |
| Mar 2014 | - | -$27.05M(+95.5%) | -$72.49M(+25.6%) |
| Dec 2013 | -$57.69M(+13.1%) | -$13.84M(-8.2%) | -$57.69M(+3.9%) |
| Sep 2013 | - | -$15.08M(-8.7%) | -$55.51M(+4.8%) |
| Jun 2013 | - | -$16.52M(+34.8%) | -$52.97M(+12.0%) |
| Mar 2013 | - | -$12.26M(+5.2%) | -$47.28M(-7.3%) |
| Dec 2012 | -$51.02M(+197.9%) | -$11.65M(-7.1%) | -$51.02M(+29.6%) |
| Sep 2012 | - | -$12.54M(+15.8%) | -$39.37M(+46.7%) |
| Jun 2012 | - | -$10.83M(-32.3%) | -$26.83M(+67.7%) |
| Mar 2012 | - | -$15.99M | -$15.99M |
| Dec 2011 | -$17.13M | - | - |
FAQ
- What is Agios Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals annual FCF year-on-year change?
- What is Agios Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals quarterly FCF year-on-year change?
- What is Agios Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals TTM FCF year-on-year change?
What is Agios Pharmaceuticals annual free cash flow?
The current annual FCF of AGIO is -$391.53M
What is the all time high annual FCF for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high annual free cash flow is $28.65M
What is Agios Pharmaceuticals annual FCF year-on-year change?
Over the past year, AGIO annual free cash flow has changed by -$76.97M (-24.47%)
What is Agios Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of AGIO is -$112.25M
What is the all time high quarterly FCF for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high quarterly free cash flow is $155.09M
What is Agios Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, AGIO quarterly free cash flow has changed by -$12.25M (-12.25%)
What is Agios Pharmaceuticals TTM free cash flow?
The current TTM FCF of AGIO is -$403.77M
What is the all time high TTM FCF for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high TTM free cash flow is $72.72M
What is Agios Pharmaceuticals TTM FCF year-on-year change?
Over the past year, AGIO TTM free cash flow has changed by -$84.79M (-26.58%)